top of page

Form CRS Background

​

On June 5, 2019, the Securities and Exchange Commission adopted a package of rulemakings and interpretations designed to enhance the quality and transparency of retail investors’ relationships with investment advisers and broker-dealers, bringing the legal requirements and mandated disclosures in line with reasonable investor expectations, while preserving access (in terms of choice and cost) to a variety of investment services and products. Specifically, these actions include new Regulation Best Interest, the new Form CRS Relationship Summary, and two separate interpretations under the Investment Advisers Act of 1940.

​

Individually and collectively, these actions are designed to enhance and clarify the standards of conduct applicable to broker-dealers and investment advisers, help retail investors better understand and compare the services offered and make an informed choice of the relationship best suited to their needs and circumstances, and foster greater consistency in the level of protections provided by each regime, particularly at the point in time that a recommendation is made.

​

Below are several different client relationship summaries (CRS). The vast majority of my business is fee based advisory in nature and therefore my FORM CRS (Client Relationship Summary) is the CIAS (Capital Investment Advisory Services) Form CRS. 

 

Occasionally I may act in a different capacity for my clients (i.e. providing long term care insurance, investing in a bond and charging a commission, or investing in an held away alternative investment such as privately held real estate investment trusts) and therefore one of the other client relationship summary forms listed below may apply. I will always act in your best interest and apply the appropriate form below to the appropriate investment if other than fee based advisory (CIAS).  

FORM CRS 

CAPITAL INVESTMENT 

ADVISORY SERVICES

(CIAS)

FORM CRS CLIENT SIGNATURE

FORM CRS

CAPITAL INVESTMENT BROKERAGE

FORM CRS

CAPITAL INVESTMENT

GROUP

bottom of page